(208) ENDOVASCULAR TREATMENT OF ERECTILE DYSFUNCTION

Endovascular treatments for refractory patients vasculogenic erectile dysfunction have increased in popularity, including angioplasty or stenting for insufficiency arterial. We attempted to validate whether dilation plus stenting of the pudendal arteries, as described for coronary arteries, is useful for the ED treatment.

We evaluated 6 patients diagnosed with ED due to arterial insufficiency

Inclusion criteria:

IIEF < 10

ED refractory to oral pharmacotherapy and intracavernous prostaglandin

Diagnosis of stenosis or occlusion of pelvic and penile arteries: using penile Doppler (peak systolic velocity < 30cm/) and confirmed by CT angiography.

Technique: 6-F sheath was placed at the origin of theinternal pudendal for selective angiography. Revascularization was indicated if the stenosis was >50%. Balloon angioplasty drug coated from 2 to 5 mm. If the dilation was not satisfactory, a drug-eluting stent was implanted. The revascularization of bilateral lesions was performed in 2 stages. All patients were treated by the same operator.

Patients were premedicated with acetylsalicylic acid (100 mg/d). And then with tadalafil (5 mg/day) for 3 weeks

Technical success was ultimately defined by patency on angiography after successful deployment of a stent or of the dilation balloon.

Clinical success was defined as an improvement >4 points on the IIEF, the ability to perform penetrative sex, or subjective improvement.of erectile function.

The average age of our patients was 62 years. The follow-up time of 12 months. In one patient it was not posible dilate the problem artery.

In one patient the internal iliac had to be previously dilated with a stent.

Only one patient achieved improved erection helped with IPD5.

Data defend that angioplasty of the penile artery is safe and improves erectile function in 60% of patients with isolated penile artery stenosis.

Our results are very poor, not achieving the desired cost-effectiveness.

None.